Showing results (151-160 of 249) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|August 24, 1985
Uridine monophosphate kinase 3: a genetic marker for susceptibility to Haemophilus influenzae type B diseaseG M Petersen, D R Silimperi, E M Scott, et al.
Ecology|June 6, 2021
A hidden Markov model for estimating age-specific survival when age and size are uncertainTimothy A Gowan, Michael D Tringali, Jeffrey A Hostetler, et al.
Peerj|October 21, 2016
Exclusions for resolving urban badger damage problems: outcomes and consequencesAlastair I Ward, Jason K Finney, Sarah E Beatham, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Uridine monophosphate kinase and susceptibility to invasive Haemophilus influenzae type B diseaseG M Petersen, D R Silimperi, E M Scott, et al.
Food & Function|June 5, 2020
Phenolic content, anti-inflammatory properties, and dermal wound repair properties of industrially processed and non-processed acai from the Brazilian AmazonJia Xiong, Fernanda V Matta, Mary Grace, et al.
The Journal of Infectious Diseases|October 1, 1996
Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trialK M Zangwill, C M Vadheim, A M Vannier, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|January 1, 1997
Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitorsDorne R Yager, S M Chen, S I Ward, et al.
Infection and Immunity|November 24, 2004
Acellular pertussis vaccines and complement killing of Bordetella pertussisAlison A Weiss, Angela K Patton, Scott H Millen, et al.
Infection and Immunity|December 1, 1993
Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharideM T Jelonek, S J Chang, C Y Chiu, et al.
JAMA|February 27, 1991
Protective efficacy of Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and olderD P Greenberg, C M Vadheim, N Bordenave, et al.
Pageof 25